Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter Pekos Insider Profile
4 Followers
Peter Pekos, Director at Cardiol Therapeutics, holds 1.01M shares in Cardiol Therapeutics (Ticker: CRDL). Most recently, Peter Pekos Bought $38,750 shares of Cardiol Therapeutics on Dec 19, 2024 for an estimated value of 49.97K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-2.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Peter Pekos holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 06, 2020 - Jun 06, 2021
Return:+46.80%
The most profitable trade made by Peter Pekos
Peter Pekos's Trading History
List of latest transactions for each holding click on a transaction to see Peter Pekos's performance on stock
You May Also Like
Peter Pekos insider profile FAQ
What is the percentage of profitable transactions made by Peter Pekos?
The percentage of profitable transactions made by Peter Pekos is 33%.
What is the average return per transaction made by Peter Pekos?
The average return per transaction made by Peter Pekos is -2.20%.
What stocks does Peter Pekos hold?
Peter Pekos holds: CRDL stocks.
What was Peter Pekos’s latest transaction?
Peter Pekos latest transaction was an Informative Buy of $49.97K.
What was Peter Pekos's most profitable transaction?
Peter Pekos’s most profitable transaction was an Informative Buy of CRDL stock on June 6, 2020. The return on the trade was 46.80%.
What is Peter Pekos's role in Cardiol Therapeutics?
Peter Pekos's role in Cardiol Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.